Barclays Maintains Overweight on Keurig Dr Pepper, Lowers Price Target to $39
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper but lowers the price target from $41 to $39.
October 28, 2024 | 2:11 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper but lowers the price target from $41 to $39.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some caution. This mixed signal may result in a neutral short-term impact on KDP's stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100